Literature DB >> 9259996

Pathways for oxidation of low density lipoprotein by myeloperoxidase: tyrosyl radical, reactive aldehydes, hypochlorous acid and molecular chlorine.

J W Heinecke1.   

Abstract

Many lines of evidence implicate oxidation of low density lipoprotein (LDL) in the pathogenesis of atherosclerosis, a chronic inflammatory disease. The physiologically relevant mechanisms have not been identified, but phagocytic white cells may play an important role because macrophage-rich lesions characterize the disorder. Recent studies have shown that myeloperoxidase, a heme enzyme secreted only by phagocytes, is present in human atherosclerotic tissue. The enzyme is a potent catalyst of LDL oxidation in vitro, it co-localizes with macrophages in lesions, and it generates products that are detectable in atherosclerotic plaque. These findings suggest that myeloperoxidase may promote LDL oxidation in the artery wall. This article reviews the enzyme's ability to generate a range of oxidants, including tyrosyl radical, reactive aldehydes, hypochlorous acid and molecular chlorine. These products have the potential to damage host molecules as well as microbes, suggesting a mechanism that may contribute to atherosclerotic vascular disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259996     DOI: 10.1002/biof.5520060208

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  14 in total

Review 1.  Effects of antioxidants against atherosclerosis.

Authors:  Etsuo Niki; Noriko Noguchi
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

2.  Immunolocalization of hypochlorite-induced, catalase-bound free radical formation in mouse hepatocytes.

Authors:  Marcelo G Bonini; Arno G Siraki; Boyko S Atanassov; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2006-11-22       Impact factor: 7.376

Review 3.  Molecular imaging of cerebrovascular lesions.

Authors:  Nohra Chalouhi; Pascal Jabbour; Vincent Magnotta; David Hasan
Journal:  Transl Stroke Res       Date:  2013-10-23       Impact factor: 6.829

Review 4.  Oxidized low-density lipoprotein.

Authors:  Sampath Parthasarathy; Achuthan Raghavamenon; Mahdi Omar Garelnabi; Nalini Santanam
Journal:  Methods Mol Biol       Date:  2010

5.  Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.).

Authors:  C Roger White; Geeta Datta; Paulina Mochon; Zhenghao Zhang; Ollie Kelly; Christine Curcio; Dale Parks; Mayakonda Palgunachari; Shaila Handattu; Himanshu Gupta; David W Garber; G M Anantharamaiah
Journal:  Vasc Dis Prev       Date:  2009-01-01

Review 6.  Dysfunctional HDL and atherosclerotic cardiovascular disease.

Authors:  Robert S Rosenson; H Bryan Brewer; Benjamin J Ansell; Philip Barter; M John Chapman; Jay W Heinecke; Anatol Kontush; Alan R Tall; Nancy R Webb
Journal:  Nat Rev Cardiol       Date:  2015-09-01       Impact factor: 32.419

7.  Bivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase.

Authors:  Volker Rudolph; Tanja K Rudolph; Francisco J Schopfer; Gustavo Bonacci; Denise Lau; Katalin Szöcs; Anna Klinke; Thomas Meinertz; Bruce A Freeman; Stephan Baldus
Journal:  J Pharmacol Exp Ther       Date:  2008-08-13       Impact factor: 4.030

8.  Spinal Cord Inflammation: Molecular Imaging after Thoracic Aortic Ischemia Reperfusion Injury.

Authors:  Hassan Albadawi; John W Chen; Rahmi Oklu; Yue Wu; Gregory Wojtkiewicz; Benjamin Pulli; John D Milner; Richard P Cambria; Michael T Watkins
Journal:  Radiology       Date:  2016-08-10       Impact factor: 11.105

9.  Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis.

Authors:  John W Chen; Michael O Breckwoldt; Elena Aikawa; Gloria Chiang; Ralph Weissleder
Journal:  Brain       Date:  2008-01-29       Impact factor: 13.501

10.  Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina.

Authors:  Xi-Qin Ding; Alexander B Quiambao; J Browning Fitzgerald; Mark J Cooper; Shannon M Conley; Muna I Naash
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.